NEW YORK – A small startup called SimplSeq thinks its technology is going to revolutionize sequencing sample prep and ultimately usurp the behemoths in the field.
A spinout of a new tech incubator called Murrieta Genomics, the firm is now beta testing a technology that it claims is faster and simpler than standard methods, and can enable better use of precious liquid biopsy sample material.
Get the full story with
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.